$AMGN
Amgen Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA
AMGN chart
What traders are saying about $AMGN
Latest postsAmgen Inc news
- Beyond the DNA We Inherit: A Broader View of Human Genetics
Amgen ·
- AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026
Yahoo Finance ·
- Amgen receives FDA warning letter over Vectibix ad
Seeking Alpha ·
- Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
fool.com ·
- FDA warns Amgen over cancer drug promotional video
Reuters ·
- FDA Terms Amgen's Vectibix Promotional Video Misleading, Orders Ceasure Of Communications
TradingView ·
- Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
Yahoo Finance ·
- Fund Update: 28,528 AMGEN (AMGN) shares added to Crestwood Advisors Group, LLC portfolio
Quiver Quantitative ·
- Has Regeneron Stock Become A Different Bet?
trefis.com ·
- Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
fool.com ·
- Jefferies lifts target for Amgen stock to USD 428.00
ad-hoc-news.de ·
- Amgen stock may move 4.3% on earnings release next week By Investing.com
Investing.com Australia ·
Amgen Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B |
| Diluted EPS | $14.23 | $7.56 | $12.49 | $12.11 |
| Total assets (year end) | $90.59B | $91.84B | $97.15B | $65.12B |
| Cash and equivalents (year end) | $9.13B | $11.97B | $10.94B | $7.63B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amgen Inc
- Ticker
- AMGN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Thousand Oaks, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 318154
Frequently asked questions
What exchange is Amgen Inc listed on?
Amgen Inc trades on the Nasdaq under the ticker symbol AMGN.
What industry is Amgen Inc in?
Amgen Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Amgen Inc headquartered?
Amgen Inc's business address on file with the SEC is in Thousand Oaks, CA.
When does Amgen Inc's fiscal year end?
Amgen Inc's fiscal year ends on December 31.
How much revenue did Amgen Inc report?
Amgen Inc reported $36.75B in revenue for calendar year 2025, according to its SEC filings.